TickerFacts.

Bicycle Therapeutics PLC (BCYC): Capital Expenditures

Annual figures by period end, from SEC filings.

$2.35M
Year ended 2025-12-31
$2.23M
Trailing 12 months to 2026-06-30
-50.2%
3-year compound annual growth
+14.4%
5-year compound annual growth
$18.99M2017-12-31: $1.11M2018-12-31: $1.19M2019-12-31: $1.55M2020-12-31: $1.20M2021-12-31: $2.03M2022-12-31: $18.99M2023-12-31: $2.93M2024-12-31: $1.24M2025-12-31: $2.35M$2.35M
2017-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$2.35M+90.3%2026-03-17, From 2025-01-01
2024-12-31$1.24M-57.8%2026-03-17, From 2024-01-01
2023-12-31$2.93M-84.6%2026-03-17, From 2023-01-01
2022-12-31$18.99M+835.3%2025-02-25, From 2022-01-01
2021-12-31$2.03M+69.2%2024-02-20, From 2021-01-01
2020-12-31$1.20M-22.8%2023-02-28, From 2020-01-01
2019-12-31$1.55M+31.1%2022-03-01, From 2019-01-01
2018-12-31$1.19M+6.6%2021-03-11, From 2018-01-01
2017-12-31$1.11Mn/a2020-03-10, From 2017-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Bicycle Therapeutics PLC (BCYC)2025-12-31$2.35M+90.3%
Assembly Biosciences, Inc. (ASMB)2025-12-31$66.0K+135.7%
Viridian Therapeutics, Inc. (VRDN)2025-12-31$495.0K-3.1%
AbCellera Biologics Inc. (ABCL)2025-12-31$42.77M-45.4%
Rockwell Medical, Inc. (RMTI)2025-12-31$542.0K-46.4%
CytomX Therapeutics, Inc. (CTMX)2025-12-31$220.0K-29.0%
Kura Oncology, Inc. (KURA)2025-12-31$6.64Mn/m
Eton Pharmaceuticals, Inc. (ETON)2025-12-31$333.0Kn/m
Enanta Pharmaceuticals Inc (ENTA)2025-09-30$12.90M-28.1%

Compare BCYC, ASMB, VRDN, ABCL side by side · Screen every company in Pharmaceutical Preparations ↗